News & Events

Learn about what's new with CMC Biologics

AGC Biologics Expands Plasmid DNA Offering

News

SEATTLE, December 11, 2019-- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, is significantly expanding its CDMO services with plasmid DNA (pDNA) offerings from its Heidelberg site in Germany. With the demand for pDNA growing rapidly, AGC Biologics is leveraging 25 years of experience and comprehensive in-house analytics development to ensure customers short and dependable timelines.

Follow Us
Join us on LinkedIn Follow us on Twitter